Regulation of glioblastoma cells by GABAergic neurons in human organoid-tumor chimeras
Regulation of glioblastoma cells by GABAergic neurons in human organoid-tumor chimeras
批准号:
10643308
负责人:
Oleksandr Shcheglovitov
金额:
$21.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-06 至 2025-03-31
关键词:
AdultAffectBrainBrain NeoplasmsCell Adhesion MoleculesCell CommunicationCell ProliferationCell SurvivalCellsCentral Nervous SystemChemical SynapseChemicalsChildChimera organismClinical TrialsCoculture TechniquesCommunicationDiagnosisElectrophysiology (science)EnvironmentEthicsExcitatory SynapseExhibitsFunctional disorderFutureGABA ReceptorGene ExpressionGlioblastomaGliomaGlutamatesGoalsGrowthGrowth FactorHumanIndividualMalignant neoplasm of central nervous systemMeasuresMediatingMembrane PotentialsMolecularMusNeuronsNeurosciencesNormal CellOrganoidsPathogenesisPathologyPatientsPharmacologyPrimary Brain NeoplasmsProliferatingPropertyPublic HealthRegulationResearchRoleSignal TransductionSignaling ProteinSliceSpecificitySynapsesSystemTechniquesTestingTumor PromotionTumor TissueWorkcancer cellcell typeeffective therapyexcitatory neuronexperimental studygamma-Aminobutyric Acidhuman stem cellsimprovedin vivoinduced pluripotent stem cellinnovationinsightmortalityneoplastic cellnerve stem cellneuroligin 1neuroligin 3neuroregulationnew therapeutic targetnoveloptogeneticspatch clamppediatric patientspostsynapticpresynaptic neuronsrabies viral tracingresponsesingle-cell RNA sequencingstem cellstherapeutic targettooltumortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Glioblastoma (GBM, WHO Grade IV glioma) is one of the most common and deadliest primary brain tumors that
affects both children and adults. GBM is associated with significantly elevated mortality, and there are no
effective therapies available for patients despite many previous clinical trials. It is believed that a better
understanding of the cell types and factors regulating GBM cell properties in the brain could provide novel
insights into the pathology and reveal new therapeutic targets for treating GBM patients. The main goal of this
R21 proposal is to elucidate the role of human GABAergic neurons in regulating the proliferation and survival of
GBM cells in the brain using an innovative co-culture approach of human GBM spheroids and human induced
pluripotent stem cell (iPSC)-derived telencephalic organoids (organoid-GBM chimera). To achieve this goal, we
will use the most advanced neuroscience tools and techniques, including human stem cell-derived brain
organoids, optogenetics, rabies virus tracing, and single-cell RNA sequencing, to characterize the
communication between GABAergic neurons and tumor cells in organoid-GBM chimera and the effects of this
communication on tumor cell survival and proliferation. Our specific hypothesis is that GABAergic neurons form
functional synapses with tumor cells in GBM-organoid chimeras to promote tumor cell proliferation or survival
via GABA-mediated depolarization of tumor cells. The specific aims to test this hypothesis are (1) to determine
whether GABAergic neurons establish functional synapses with GBM cells to regulate tumor growth and survival
and (2) to determine the role of trans-synaptic signaling proteins in regulating tumor growth and survival. Overall,
we expect that this study will advance our understanding of the cellular and molecular mechanisms involved in
the regulation of GBM cell properties in the human brain and provide a novel framework for studying the
interactions of human brain tumors with human neurons in a human brain-like environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assembly and characterization of human cortico-striatal neural networks
-
批准号:10629418
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2021
-
负责人:Oleksandr Shcheglovitov
-
依托单位:
Assembly and characterization of human cortico-striatal neural networks
-
批准号:10458691
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2021
-
负责人:Oleksandr Shcheglovitov
-
依托单位:
Assembly and characterization of human cortico-striatal neural networks
-
批准号:10290264
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2021
-
负责人:Oleksandr Shcheglovitov
-
依托单位:
Cellular and molecular mechanisms disrupted in 22q13 deletion syndrome and autism
-
批准号:10084752
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2018
-
负责人:Oleksandr Shcheglovitov
-
依托单位:
Cellular and molecular mechanisms disrupted in 22q13 deletion syndrome and autism
-
批准号:10326382
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2018
-
负责人:Oleksandr Shcheglovitov
-
依托单位:
海外基金